Title

close iconicon dots

T1D Guide

T1D Strong News

Personal Stories

Resources

T1D Misdiagnosis

T1D Early Detection

Research/Clinical Trials

Sanofi’s “The 1 Pledge” Advocates for Early Screening

You’re at the movies, and suddenly, an ad about T1D testing pops up on the big screen. Sanofi’s “Screen it Like You Mean It, and “#1 Pledge” campaigns are becoming mainstream. With so many research programs and early detection efforts gaining traction, you may wonder why type 1 testing is so important.

Sanofi’s “The 1 Pledge” Advocates for Early Screening

Why T1D Early Detection Matters

You may be thinking, ‘If I carry the type 1 gene, what does it matter if I know ahead of time—there’s no cure…'

Here's why in a a nutshell: 

Type 1 diabetes management and preparedness are crucial.

The most important reason to get tested is to avoid the life-threatening complication of diabetes ketoacidosis (DKA). Individuals can reduce the long-term side effects we’ve seen in many misdiagnosed cases.

Early detection of T1D allows people to research and educate themselves, find doctors, and develop a treatment plan to better prepare.

Disease modifying therapies.

Another top reason why you should test for type 1 diabetes is because new medications can stall the disease's onset. Tzield is one of the first disease-modifying therapies (DMT) approved by the FDA to delay the onset of type 1 diabetes. The medication slows the autoimmune destruction of beta cells in the pancreas, allowing the body to continue producing insulin in some cases for up to two years, which delays the financial and emotional burdens.

Other ongoing research explores treatments to delay and prevent the T1D progression by creating access to potential new therapies.

Type 1 diabetes is on the rise in adults.

According to current research, the global trend shows type 1 diabetes is on the rise, with diabetes (both type 1 and 2) in young people increasing steadily over the next 40 years.

The disease that was once thought to be prominent in children and adolescents is seeing significant growing cases in adults.

Both genetics and environmental factors cause type 1 diabetes.

Studies indicate genetic susceptibility, where individuals need to inherit risk factors from both parents. If someone in a family has T1D, it is approximately 15 times more likely to manifest in another family member. However, up to 90% of people with type 1 diabetes do not have a family history.

The American Diabetes Association (ADA) reports that since not everyone at risk gets the disease, environmental triggers, such as climate, diet, or a possible virus, must be involved. Moreover, some studies show a potential surge in cases during the COVID-19 pandemic.

Sanofi’s T1D Movement

Sanofi, a leader in diabetes care, launched the “Screen it Like You Mean It” and “The 1 Pledge” national campaigns in 2023. These movements encourage early detection and T1D screening, showcasing diversity in the T1D community.

By including celebrities like Usher Raymond IV (Usher’s son was diagnosed at age 6), Robin Arzón (VP of Fitness Programming and Head Instructor at Peloton and best-selling author), and Adam Schefter (journalist whose wife Sharri Maio lives with T1D) to open up about their T1D experience, they’ve encouraged people to get screened.

“Since the day my child was diagnosed with type 1 diabetes, the condition is something I never stop thinking about. Had we detected my child’s type 1 diabetes before their diagnosis, it could have given us valuable time to prepare.” USHER

The promotion's storytelling includes everyday patients battling type 1 and caregivers who wish they had known how to better prepare for the grueling management. The 1 Pledge encourages people to get tested before symptoms arise and urges families to get screened to better prepare for illness.

While there is still no cure for type 1 diabetes, early screening through blood antibody tests can give people more time to prepare.

The #1Pledge

The slogan, now appearing in movie theaters, doctor offices, and television commercials, supports people getting screened for T1D, especially if they have a family history with the disease. It advocates for early testing before possible life-threatening complications arise and the need for insulin if spotted early enough.

Sanofi’s Survey

The innovative global company has taken a new approach to reaching an untapped audience. Sanofi, alongside BeyondType1, surveyed 1,000 T1D adults and 1,000 caregivers of children with type 1 to prove that this early detection initiative benefits patients and caregivers.

The "Cost of Not Knowing" study found that most individuals “regretted not testing sooner.” Also, newly diagnosed T1D’s shared the dangers of avoidance and unawareness.

“As many as 40% of people have no idea they have T1D until they experience a life-threatening event that requires hospitalization. So don’t wait.” —Screen It Like You Mean It.

Other Reasons to Screen

Living in denial can have financial repercussions as well as emotional and social problems.

Sanofi’s study unveiled:

  • 50% of adults with type 1 diabetes spent $5,000 on emergency care for their T1D symptoms before or during diagnosis, with nearly one in four spending at least $10,000.
  • 72% of adults who did not screen and 66% of caregivers were unaware that a T1D autoantibody test was available!
  • 92% of T1D adults recommended friends and family members get tested to understand the risks.

Before screening, it’s essential to know the Stages of T1D:

  • Stage 1: Autoantibodies appear in the blood, but glucose levels are normal. 
  • Stage 2: Glucose tolerance is impaired, but usually no symptoms. 
  • Stage 3: Clinical type 1 diabetes develops, with signs and symptoms.

How do I get Screened?

Here are five ways to screen for the risks of T1D.

1) Screening Central

The Screening Central platform was developed in collaboration with Sanofi. The telehealth service offers various screening options: You can visit a local lab or have a kit sent to your home to complete and return. Visit Sanofi’s Screening Central for more information on screening tests.

2) Simple Blood Test

Though growing increasingly more common, specific blood tests can determine if you have type 1 diabetes. Unlike a blood glucose test, the autoantibody test screens for diabetes-related autoantibodies (proteins in the blood visible in the early stages before symptoms.) Ask your healthcare team for details.

3) Autoimmunity Screening for Kids (ASK)

ASK provides a free autoantibody test to all children in the United States.

4) Type 1 Diabetes TrialNet

If you have a relative with type 1 diabetes, TrialNet will mail you a free test kit to be taken at home or in a participating lab.

5) Enable Biosciences

The biotech company Enable Biosciences has developed a test kit to detect type 1 diabetes. They offer an at-home test or one that you can get from a doctor’s office.

Visit Screen It Like You Mean It

The website provides diabetes counselors with information about the screening process. To speak to a counselor, call 855-576-8471.

What is the cost of a test?

The various screening options offer different costs, and lab screenings vary depending on your insurance coverage. Speak with your doctor and insurance provider for the best-cost screening method. If you have a family member with T1D, TrialNet offers free testing.

Cassie Bailey of the @wildthornbaileys “wishes she’d been better prepared for her son’s type 1 diabetes diagnosis. Cassie’s son was five years old at the time of his T1D diagnosis and developed DKA. Cassie and her husband had to learn practically overnight how to help their son manage the disease.

Knowledge is Power – T1D Preparedness Matters

Early testing is key, even if you don’t have any symptoms. Determining a T1D prognosis allows for better disease management and can, in some instances, delay the need for insulin with new medications for up to two years.

Finding the right care team and T1D community can be crucial for getting ahead of the curve.

People can pledge to get screened for type 1 diabetes today at The1Pledge.com and follow the movement on social media using #ScreenforType1. Sanofi and T1D Strong encourage people interested in learning more about screening or type 1 diabetes to speak to their doctor.

Latest News

Read all
arrow
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
T1D Strong DNA test has been awarded at ADA 2024 conference

Our DNA test is selected as one of the finalists for the American Diabetes Association Innovation Challenge 2024!

T1D Team

T1D Team

T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Achieving the Milestone - 100 Articles Published!

We're just getting started! Committed to empowering the T1D community, we continue to share knowledge and stories.

T1D Team

T1D Team

Read all
arrow

Related Articles

The latest news, technologies, and resources from our team.

New Disease-Modifying Therapies that Delay T1D Onset
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
New Disease-Modifying Therapies that Delay T1D Onset
Diet & Lifestyle Tips for Women in Perimenopause & Menopause with T1D
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Diet & Lifestyle Tips for Women in Perimenopause & Menopause with T1D
Autoimmunity Screening for Kids (ASK) Program
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Autoimmunity Screening for Kids (ASK) Program
Denosumab: Another Reason to Screen for T1D 
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Denosumab: Another Reason to Screen for T1D 
Meet T1D Jonathan Rigby, President & CEO of Sernova Corp
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Meet T1D Jonathan Rigby, President & CEO of Sernova Corp
Sana Biotech’s Cell Therapy without Immunosuppression is a Gamechanger
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Sana Biotech’s Cell Therapy without Immunosuppression is a Gamechanger
10 Highlights of the ADA 2025 Standards of Care
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
10 Highlights of the ADA 2025 Standards of Care
I’ve Screened My Children for the Autoantibodies of Type 1 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
I’ve Screened My Children for the Autoantibodies of Type 1 Diabetes
Eversense 365—The New One-Year CGM
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Eversense 365—The New One-Year CGM
How to Reverse Prediabetes Naturally
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
How to Reverse Prediabetes Naturally
First T1D Functional Cure Using Immunosuppressive Therapy
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
First T1D Functional Cure Using Immunosuppressive Therapy
Diatech Diabetes Co-Founders John Wilcox & Luis E. Blanco
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Diatech Diabetes Co-Founders John Wilcox & Luis E. Blanco
Health2Sync Offers Diabetes Management Solutions to Users Worldwide
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Health2Sync Offers Diabetes Management Solutions to Users Worldwide
DiabeticU: An All-in-One Diabetes Health Platform
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
DiabeticU: An All-in-One Diabetes Health Platform
Pillar of Health is Reshaping Healthcare in Rwanda for T1Ds
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Pillar of Health is Reshaping Healthcare in Rwanda for T1Ds
Heroic Diabetes Founder Jaren Smith
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Heroic Diabetes Founder Jaren Smith
Diabetes Psychologist and Author Mark Heyman
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Diabetes Psychologist and Author Mark Heyman
Meet ADA Innovation Challenge Winner Katharine Barnard-Kelly
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Meet ADA Innovation Challenge Winner Katharine Barnard-Kelly
12 Best Diabetes Apps of 2024
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
12 Best Diabetes Apps of 2024
Type 1 Diabetes Screening – Here’s What You Need to Know
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Type 1 Diabetes Screening – Here’s What You Need to Know
A Simple Way to Prevent Misdiagnosing Type 1 & Type 2 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
A Simple Way to Prevent Misdiagnosing Type 1 & Type 2 Diabetes
T1D Highlights from the ADA 84th Scientific Sessions
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
T1D Highlights from the ADA 84th Scientific Sessions
International Wellness Coach Lisa La Nasa on Thriving with Diabetes 
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
International Wellness Coach Lisa La Nasa on Thriving with Diabetes 
JDRF is Now Breakthrough T1D™
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
JDRF is Now Breakthrough T1D™
Breakthrough T1D (Formerly JDRF) Offers Resources to Adults with Type 1 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Breakthrough T1D (Formerly JDRF) Offers Resources to Adults with Type 1 Diabetes
Type 1 Diabetes and Family History
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Type 1 Diabetes and Family History
Different Types of Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Different Types of Diabetes
Type 1 Diabetes Testing
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Type 1 Diabetes Testing
Gluroo: A User-Friendly App that Streamlines Diabetes Management
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Gluroo: A User-Friendly App that Streamlines Diabetes Management
The Down Low on DKA
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
The Down Low on DKA
Top Nutrition Tips from Registered Dietitian Rachel Stahl Salzman
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Top Nutrition Tips from Registered Dietitian Rachel Stahl Salzman
The Special Diabetes Program and Why it’s Important
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
The Special Diabetes Program and Why it’s Important
Neil Israel, master animator and diabetes educator
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Neil Israel, master animator and diabetes educator
DiabetesSangha – A Meditation Community Where All is Welcome
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
DiabetesSangha – A Meditation Community Where All is Welcome
Kerry Murphy - Founder of FOLLOWT1Ds Advocates for Schools to Remote Monitor Students with T1D 
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Kerry Murphy - Founder of FOLLOWT1Ds Advocates for Schools to Remote Monitor Students with T1D 
Diabetes and Addiction
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Diabetes and Addiction
Interview with Breakthrough T1D (Formerly JDRF) Market Director, Mike Somers
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Interview with Breakthrough T1D (Formerly JDRF) Market Director, Mike Somers
Connected in Motion: A Diabetes Camp for Adults
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Connected in Motion: A Diabetes Camp for Adults
StartUp Health’s T1D Moonshot Ignites a Call to Action 
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
StartUp Health’s T1D Moonshot Ignites a Call to Action 
Empowering Lives: Nonprofits Making a Difference in the Type 1 Diabetes Community
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Empowering Lives: Nonprofits Making a Difference in the Type 1 Diabetes Community
Spotlight on Diabetes Educator Carla Cox
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Spotlight on Diabetes Educator Carla Cox
Enhance-d: A Software Solution to Simplify Glucose Management
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Enhance-d: A Software Solution to Simplify Glucose Management
Diabetes and School - Know Your Rights
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Diabetes and School - Know Your Rights
Enable Biosciences – Transforming Early T1D Detection
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Enable Biosciences – Transforming Early T1D Detection
Undermyfork, a Mobile App Success in Diabetes Management
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Undermyfork, a Mobile App Success in Diabetes Management
Diabetes Support Groups for Young Adults
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Diabetes Support Groups for Young Adults
Load More
background image

Knowledge Base

Resources

Knowledge hub for advanced information on Type 1 Diabetes.

Learn more

arrow

Personal Stories

Life stories of relentless individuals fostering resilience and empowering others.

Learn more

arrow

T1D Strong News

Stay updated with the latest from T1D Strong: product updates, company events, notable achievements and our future plans.

Learn more

arrow

T1D Guide

Strategies to enhance lifestyle optimization with Type 1 Diabetes.

Learn more

arrow

T1D Early Detection

Discover advanced screening methods for early T1D detection. Learn about breakthrough diagnostics and early signs for proactive management.

Learn more

arrow

Research/Clinical Trials

Explore the latest breakthroughs in clinical research and trials. Stay informed about innovative treatments and scientific discoveries shaping the future of medicine.

Learn more

arrow

T1D Misdiagnosis

Understanding common queries and exclusive information about diabetes of any type.

Learn more

arrow